1. Home
  2. TSHA vs LZB Comparison

TSHA vs LZB Comparison

Compare TSHA & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • LZB
  • Stock Information
  • Founded
  • TSHA 2019
  • LZB 1927
  • Country
  • TSHA United States
  • LZB United States
  • Employees
  • TSHA N/A
  • LZB N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • LZB Home Furnishings
  • Sector
  • TSHA Health Care
  • LZB Consumer Discretionary
  • Exchange
  • TSHA Nasdaq
  • LZB Nasdaq
  • Market Cap
  • TSHA 1.2B
  • LZB 1.3B
  • IPO Year
  • TSHA 2020
  • LZB N/A
  • Fundamental
  • Price
  • TSHA $4.87
  • LZB $39.87
  • Analyst Decision
  • TSHA Strong Buy
  • LZB Strong Buy
  • Analyst Count
  • TSHA 9
  • LZB 2
  • Target Price
  • TSHA $10.22
  • LZB $42.50
  • AVG Volume (30 Days)
  • TSHA 3.9M
  • LZB 689.4K
  • Earning Date
  • TSHA 11-04-2025
  • LZB 11-18-2025
  • Dividend Yield
  • TSHA N/A
  • LZB 2.23%
  • EPS Growth
  • TSHA N/A
  • LZB N/A
  • EPS
  • TSHA N/A
  • LZB 2.16
  • Revenue
  • TSHA $6,310,000.00
  • LZB $2,107,357,000.00
  • Revenue This Year
  • TSHA N/A
  • LZB $2.12
  • Revenue Next Year
  • TSHA N/A
  • LZB $4.04
  • P/E Ratio
  • TSHA N/A
  • LZB $18.31
  • Revenue Growth
  • TSHA N/A
  • LZB 1.78
  • 52 Week Low
  • TSHA $1.05
  • LZB $29.03
  • 52 Week High
  • TSHA $5.51
  • LZB $48.31
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 62.34
  • LZB 74.70
  • Support Level
  • TSHA $3.92
  • LZB $29.03
  • Resistance Level
  • TSHA $4.34
  • LZB $38.05
  • Average True Range (ATR)
  • TSHA 0.30
  • LZB 1.07
  • MACD
  • TSHA 0.06
  • LZB 1.05
  • Stochastic Oscillator
  • TSHA 98.33
  • LZB 96.70

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About LZB La-Z-Boy Incorporated

La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.

Share on Social Networks: